Page last updated: 2024-10-29

ketanserin and Altitude Sickness

ketanserin has been researched along with Altitude Sickness in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Altitude Sickness: Multiple symptoms associated with reduced oxygen at high ALTITUDE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Papamatheakis, DG1
Vemulakonda, S1
Blood, Q1
Goyal, R1
Rubalcava, M1
Vrancken, K1
Bennett, A1
Dawson, A1
Osman, NJ1
Blood, AB1
Pearce, WJ1
Longo, LD1
Wilson, SM1

Other Studies

1 other study available for ketanserin and Altitude Sickness

ArticleYear
Preservation of serotonin-mediated contractility in adult sheep pulmonary arteries following long-term high-altitude hypoxia.
    High altitude medicine & biology, 2011,Fall, Volume: 12, Issue:3

    Topics: Altitude Sickness; Animals; Benzamides; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type;

2011